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Sarcomatoid Mesothelioma in a Patient with Asbestos
Exposure
Abhik Roy, MD and Merritt Brown, MD

Case
A 76-year-old man with no significant past medical history
presented with a two month history of progressive shortness
of breath, 25-pound weight loss, and sharp right-sided chest,
abdomen, and pelvic pain without radiation. The patient noted
his dyspnea became more pronounced in recent weeks, notably
worse with climbing stairs or performing work around the
house. He described the pain as having a positional component,
and exacerbated with deep-inspiration. On further questioning,
the patient reported a 50-pack-year history of smoking and past
exposure to asbestos while working with heating insulation.
Physical examination revealed an age-appropriate, but cachectic
appearing male with tenderness of the right abdomen to
palpation, mild tachypnea with 95% oxygen saturation on two
liters of oxygen, and normal cardiac rate and rhythm. Initial
chest radiograph revealed a large mass causing near complete
opacification of the right hemithorax (Figure 1) which was a new
finding compared to the patient’s previous chest radiograph two
years prior (Figure 2). Computed tomography (CT) scan of the
chest/abdomen/pelvis performed to further evaluate this mass
(Figure 3) revealed a 20 x 21 x 23 cm heterogeneous tumor above
the right hemidiaphragm with extension into the left atrium via
the right pulmonary vein (white arrow), as well as lateral and
anterior diaphragmatic and pleural involvement. Differential
diagnosis at this stage included malignant mass, benign pleural
wall tumor, and mesothelioma. Pathology from surgical biopsy
(Figure 4) suggested Sarcomatoid mesothelioma.

Figure 1. Chest radiograph (PA) shows a mass in the right thorax
causing left deviation of midline structures
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Mesothelioma is an aggressive, rare malignancy arising from
mesothelial cells, most commonly in the pleura, but also noted to
occur in the peritoneum, pericardium, or tunica vaginalis. Three
major histologic subtypes of mesothelioma, epithelioid (most
common), biphasic, and sarcomatoid, have been described.
Accounting for only 10% of pleural malignant mesotheliomas,
Sarcomatoid is the least common, defined by the absence of
epithelial elements in biopsy material (Figure 4). Like other
mesotheliomas, Sarcomatoid is most common in men older
than 55, and is strongly associated with distant exposure to
asbestos (particularly amphibole asbestos). Common presenting
symptoms of all malignant pleural masses include dyspnea,
weight loss, anorexia, night sweats and weakness.
Sarcomatoid type, the most aggressive subtype, shows the least
response to surgery, chemotherapy, or radiation therapy. With
a median survival near 6 months, Sarcomatoid mesothelioma is
associated with a particularly poor prognosis compared to 12-24
months for epithelial mesothelioma and 12 months for biphasic
mesothelioma. Given his poor prognosis, our patient was offered
palliative chemotherapy; however, after much discussion, he
decided to forgo any therapy and was discharged home under
the care of his family.
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Figure 2. Chest radiograph from two years prior to current
admission is unremarkable for any lesion or mass
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Figure 4. Hematoxylin & Eosin stained biopsy of right lung mass
obtained by Trucut core needle biopsy shows absence of epithelial
elements

Figure 3. Choronal computed tomography (CT) of the abdomen/
pelvis with reconstruction shows a circumscribed loculated mass
with extension into the left atrium via right pulmonary vein
(white arrow)
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